|
|
Mitochondrial DNA ND1 and ND4 mutation in liver and captured hepatocytes of mice after long-term nucleoside analogues exposure |
ZHANG Wei1* QIAO Luxin1,2* DING Wei1 CHEN Dexi1,2 ZHANG Yulin1▲ |
1.Beijing You′an Hospital, Capital Medical University, Beijing 100069, China;
2.Beijing Institute of Hepatology, Beijing 100069, China |
|
|
Abstract Objective To investigate whether long-term use of nucleoside analogues (NAs) can lead to damage of DNA (mtDNA) ND1 and ND4 regions in liver mitochondria of mice. Methods According to the simple random method, twenty-five 7-weeks-old female Balb/c mice were divided into 5 groups, with 5 cases in each group. The control group received double-distilled water by intraperitoneal injection 5 days per week for 3 months. The each test group was respectively given D4T 50 mg/kg, AZT 100 mg/kg,3TC 50 mg/kg,or DDI 50 mg/kg by intraperitoneal injection per day,5 days per week for 3 months. Single liver cell was captured from mouse liver tissues by laser capture microdissection. The products of mtDNA ND1 and ND4 region PCR amplicons were cloned and sequenced in mice liver cells. Results The mean distance to the reference sequence of mtDNA ND4 in the captured hepatocytes of AZT, D4T and 3TC groups were longer than that in the control group, the differences were statistically significant (P < 0.01). The mean mtDNA ND4 dN of the captured hepatocytes in the AZT group was higher than that in the control group, the difference was statistically significant (P < 0.05). The mean distance to the reference sequence of mtDNA ND1 in the captured hepatocytes of AZT and 3TC groups were longer than that in the control group, the differences were statistically significant(P < 0.01). The mean mtDNA ND1 dS of the liver tissue in the DDI group was higher than that in the control group, the difference was statistically significant (P < 0.05). The mean mtDNA ND1 dS of AZT and 3TC groups were higher than that in the control group, the differences were statistically significant(P < 0.05). Conclusion Long-term exposure to nucleoside analogue can result in mtDNA ND1 and ND4 regions lesion in mouse hepatocytes.
|
|
|
|
|
[1] Seto WK,Liu K,Wong DK,et al. Patterns of hepatitis B surface antigen decline and HBV DNA suppression in Asian treatment-experienced chronic hepatitis B patients after three years of tenofovir treatment [J]. J Hepatol,2013,59(4): 709-716.
[2] Obiako OR,Abdu-Aguye I,Ogunniyi A. Effect of Stavudine-Based antiretroviral therapy on the severity of polyneuropathy in HIV/AIDS patients:a preliminary report from Zaria,Northern Nigeria [J]. West Afr J Med,2011,30(5): 354-358.
[3] Dragovic G,Jevtovic D. The role of nucleoside reverse transcriptase inhibitors usage in the incidence of hyperlactatemia and lactic acidosis in HIV/AIDS patients [J]. Biomed Pharmacother,2012,66(4):308-311.
[4] 胡倩倩,时丽丽,谭初兵.核苷类似物线粒体毒性机制及临床表现[J].中国药理学与毒理学杂志,2013,27(5):885-888.
[5] 张维,乔录新,丁渭,等.核苷类似物对小鼠肝脏线粒体DNA D-loop区突变的影响[J].中国医药导报,2016,13(15):9-12.
[6] 任林柱,张英.分子生物学实验原理与技术[M].北京:科学出版社,2015.
[7] Moyle G. Toxicity of antiretroviral nucleoside and nucleotide analogues:is mitochondrial toxicity the only mechanism?[J].Drug safety,2000,23(6),467-481.
[8] Dalakas MC. Peripheral neuropathy and antiretroviral drugs [J]. J Peripher Nerv Syst,2001,6(1),14-20.
[9] Youle M. Acetyl-L-carnitine in HIV-associated antiretroviral toxic neuropathy [J]. CNS Drugs,2007,21 Suppl 1: 25-30,45-46.
[10] Antoniades C,Macdonald C,Knisely A,et al. Mitochondrial toxicity associated with HAART following liver transplantation in an HIV-infected recipient [J]. Liver transpl,2004,10(5),699-702.
[11] Laguno M,Milinkovic A,de Lazzari E,et al. Incidence and risk factors for mitochondrial toxicity in treated HIV/HCV-coinfected patients [J]. Antivir Ther,2005,10(3),423-429.
[12] Macias J,Castellano V,Merchante N,et al. Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C:harmful impact of nevirapine [J]. AIDS,2004,18(5),767-774.
[13] Antoniades C, Macdonald C, Knisely A, et al. Mitochondrial toxicity associated with HAART following liver transplantation in an HIV-infected recipient [J]. Liver Transpl,2004,10,699-702.
[14] Gu F,Chauhan V,Kaur K,et al. Alterations in mitochondrial DNA copy number and the activities of electron transport chain complexes and pyruvate dehydrogenase in the frontal cortex from subjects with autism [J]. Transl Psychiatry,2013,3,e299.doi:10.1038/tp.2013.68.
[15] Restrepo NA,Mitchell SL,Goodloe RJ,et al. Mitochondrial variation and the risk of age-related macular degeneration across diverse populations [J]. Pac Symp Biocomput,2015,243-254.
[16] Gurses C,Azakli H,Alptekin A,et al. Mitochondrial DNA profiling via genomic analysis in mesial temporal lobe epilepsy patients with hippocampal sclerosis [J]. Gene,2014,538(2),323-327.
[17] Zong NC,Li HM,Li H,et al. Integration of cardiac proteome biology and medicine by a specialized knowledgebase [J]. Circ Res,2013,113(9),1043-1053.
[18] Garlick K. The potential of combination drug therapy for hepatitis B to cause mitochondrial damage[J]. https://researchspace.auckland.ac.nz/handle/2292/22450.
[19] Zhang Y,Song F,Gao Z,et al. Long-term exposure of mice to nucleoside analogues disrupts mitochondrial DNA maintenance in cortical neurons [J]. PLoS One,2014,9(1): e85637. |
|
|
|